WallStreetZenWallStreetZen

NASDAQ: EYEN
Eyenovia Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for EYEN

Based on 1 analyst offering 12 month price targets for Eyenovia Inc

Min Forecast
$2.00-18.03%
Avg Forecast
$2.00-18.03%
Max Forecast
$2.00-18.03%

Should I buy or sell EYEN stock?

Based on 1 analyst offering ratings for Eyenovia Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their EYEN stock forecasts and price targets.

EYEN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-21

1 of 1

Forecast return on equity

Is EYEN forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is EYEN forecast to generate an efficient return on assets?

Company
-202.82%
Industry
32.45%
EYEN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

EYEN earnings per share forecast

What is EYEN's earnings per share in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$16.15
Avg 2 year Forecast
-$14.40
Avg 3 year Forecast
-$10.85

EYEN revenue forecast

What is EYEN's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$3.8M+5,625.96%
Avg 2 year Forecast
$11.3M+16,749.83%
Avg 3 year Forecast
$23.8M+35,329.37%
EYEN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

EYEN revenue growth forecast

How is EYEN forecast to perform vs Biotechnology companies and vs the US market?

Company
599.23%
Industry
56.38%
Market
9.68%
EYEN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
EYEN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

EYEN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
EYEN$2.44$2.00-18.03%Hold
CDIO$4.06N/AN/A
PMCB$1.01N/AN/A
ACXP$0.31$10.00+3,178.69%Buy
NLSP$2.28N/AN/A
View Top Biotech Stocks

Eyenovia Stock Forecast FAQ

Is Eyenovia Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: EYEN) stock is to Hold EYEN stock.

Out of 1 analyst, 0 (0%) are recommending EYEN as a Strong Buy, 0 (0%) are recommending EYEN as a Buy, 1 (100%) are recommending EYEN as a Hold, 0 (0%) are recommending EYEN as a Sell, and 0 (0%) are recommending EYEN as a Strong Sell.

If you're new to stock investing, here's how to buy Eyenovia stock.

What is EYEN's earnings growth forecast for 2025-2027?

(NASDAQ: EYEN) Eyenovia's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.33%.

Eyenovia's earnings in 2025 is -$42,379,865.On average, 1 Wall Street analyst forecast EYEN's earnings for 2025 to be -$46,557,349, with the lowest EYEN earnings forecast at -$46,557,349, and the highest EYEN earnings forecast at -$46,557,349. On average, 1 Wall Street analyst forecast EYEN's earnings for 2026 to be -$41,512,435, with the lowest EYEN earnings forecast at -$41,512,435, and the highest EYEN earnings forecast at -$41,512,435.

In 2027, EYEN is forecast to generate -$31,278,467 in earnings, with the lowest earnings forecast at -$31,278,467 and the highest earnings forecast at -$31,278,467.

What is EYEN's revenue growth forecast for 2025-2027?

(NASDAQ: EYEN) Eyenovia's forecast annual revenue growth rate of 599.23% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.68%.

Eyenovia's revenue in 2025 is $67,063.On average, 1 Wall Street analysts forecast EYEN's revenue for 2025 to be $11,069,983, with the lowest EYEN revenue forecast at $11,069,983, and the highest EYEN revenue forecast at $11,069,983. On average, 1 Wall Street analysts forecast EYEN's revenue for 2026 to be $32,575,730, with the lowest EYEN revenue forecast at $32,575,730, and the highest EYEN revenue forecast at $32,575,730.

In 2027, EYEN is forecast to generate $68,495,518 in revenue, with the lowest revenue forecast at $68,495,518 and the highest revenue forecast at $68,495,518.

What is EYEN's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: EYEN) forecast ROA is -202.82%, which is lower than the forecast US Biotechnology industry average of 32.45%.

What is EYEN's Price Target?

According to 1 Wall Street analyst that have issued a 1 year EYEN price target, the average EYEN price target is $2.00, with the highest EYEN stock price forecast at $2.00 and the lowest EYEN stock price forecast at $2.00.

The Wall Street analyst predicted that Eyenovia's share price could fall to $2.00 by Mar 21, 2026. The average Eyenovia stock price prediction forecasts a potential downside of 18.03% from the current EYEN share price of $2.44.

What is EYEN's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: EYEN) Eyenovia's current Earnings Per Share (EPS) is -$44.60. On average, analysts forecast that EYEN's EPS will be -$16.15 for 2025, with the lowest EPS forecast at -$16.15, and the highest EPS forecast at -$16.15. On average, analysts forecast that EYEN's EPS will be -$14.40 for 2026, with the lowest EPS forecast at -$14.40, and the highest EPS forecast at -$14.40. In 2027, EYEN's EPS is forecast to hit -$10.85 (min: -$10.85, max: -$10.85).

What is EYEN's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: EYEN) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.